Stage IVB Cervical Cancer Completed Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0028787 (Stage IVB Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01266447Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerTreatment